Page last updated: 2024-09-04

ezetimibe and rifampin

ezetimibe has been researched along with rifampin in 6 studies

Compound Research Comparison

Studies
(ezetimibe)
Trials
(ezetimibe)
Recent Studies (post-2010)
(ezetimibe)
Studies
(rifampin)
Trials
(rifampin)
Recent Studies (post-2010) (rifampin)
2,4845631,46520,4681,4996,552

Protein Interaction Comparison

ProteinTaxonomyezetimibe (IC50)rifampin (IC50)
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)2.949
Caspase-1Homo sapiens (human)8.319
Alpha-synucleinHomo sapiens (human)7.1
Enoyl-[acyl-carrier-protein] reductase [NADH]Mycobacterium tuberculosis H37Rv0.03
DNA-directed RNA polymerase subunit betaMycobacterium tuberculosis H37Rv0.01
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)1.5
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)1.5

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Adam, U; Cascorbi, I; Dazert, E; Fricke, C; Giessmann, T; Haenisch, S; Jedlitschky, G; Kroemer, HK; Oswald, S; Remmler, C; Siegmund, W; Sudhop, T; von Bergmann, K; Wacke, W; Warzok, R; Weitschies, W1
Giessmann, T; Luetjohann, D; Oswald, S; Rosskopf, D; Siegmund, W; Wegner, D; Weitschies, W1

Reviews

1 review(s) available for ezetimibe and rifampin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for ezetimibe and rifampin

ArticleYear
Disposition and sterol-lowering effect of ezetimibe are influenced by single-dose coadministration of rifampin, an inhibitor of multidrug transport proteins.
    Clinical pharmacology and therapeutics, 2006, Volume: 80, Issue:5

    Topics: Administration, Oral; Adult; Anticholesteremic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Azetidines; Cholesterol; Chromatography, Gas; Chromatography, Liquid; Cross-Over Studies; Enzyme Inhibitors; Ezetimibe; Feces; Female; Genotype; Glucuronides; Humans; Intestinal Absorption; Intestinal Mucosa; Intestines; Liver-Specific Organic Anion Transporter 1; Male; Multidrug Resistance-Associated Protein 2; Organic Anion Transporters; Phytosterols; Rifampin; Sitosterols; Time Factors

2006

Other Studies

4 other study(ies) available for ezetimibe and rifampin

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Intestinal expression of P-glycoprotein (ABCB1), multidrug resistance associated protein 2 (ABCC2), and uridine diphosphate-glucuronosyltransferase 1A1 predicts the disposition and modulates the effects of the cholesterol absorption inhibitor ezetimibe in
    Clinical pharmacology and therapeutics, 2006, Volume: 79, Issue:3

    Topics: Adult; Antibiotics, Antitubercular; Anticholesteremic Agents; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azetidines; Drug Interactions; Ezetimibe; Female; Glucuronosyltransferase; Humans; Intestinal Absorption; Intestinal Mucosa; Intestines; Male; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Rifampin; RNA, Messenger; Sterols; Up-Regulation

2006